Planning for tomorrow: global cancer incidence and the role of prevention 2020-2070

被引:492
作者
Soerjomataram, Isabelle [1 ]
Bray, Freddie [1 ]
机构
[1] Int Agcy Res Canc, Canc Surveillance Branch, Lyon, France
关键词
HEALTH IMPACT ASSESSMENT; MIDDLE-INCOME COUNTRIES; CERVICAL-CANCER; HUMAN-PAPILLOMAVIRUS; NORDIC COUNTRIES; COST-EFFECTIVENESS; TOBACCO CONTROL; BREAST-CANCER; FUTURE BURDEN; YOUNG-ADULTS;
D O I
10.1038/s41571-021-00514-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Assuming that the latest incidence trends continue for the major cancer types, the incidence of all cancers combined will double by 2070 relative to 2020, with the greatest increases predicted in lower-resource settings. The authors of this Perspective discuss how population-level approaches with amenable goals should be considered an integral part of cancer control. Cancer is currently the first or second most common contributor to premature mortality in most countries of the world. The global number of patients with cancer is expected to rise over the next 50 years owing to the strong influence of demographic changes, such as population ageing and growth, on the diverging trends in cancer incidence in different regions. Assuming that the latest incidence trends continue for the major cancer types, we predict a doubling of the incidence of all cancers combined by 2070 relative to 2020. The greatest increases are predicted in lower-resource settings, in countries currently assigned a low Human Development Index (HDI), whereas the predicted increases in national burden diminish with increasing levels of national HDI. Herein, we assess studies modelling the future burden of cancer that underscore how comprehensive cancer prevention strategies can markedly reduce the prevalence of major risk factors and, in so doing, the number of future cancer cases. Focusing on an in-depth assessment of prevention strategies that target tobacco smoking, overweight and obesity, and human papillomavirus infection, we discuss how stepwise, population-level approaches with amenable goals can avert millions of future cancer diagnoses worldwide. In the absence of a step-change in cancer prevention delivery, tobacco smoking will remain the leading preventable cause of cancer, and overweight and obesity might well present a comparable opportunity for prevention, given its increasing prevalence globally in the past few decades. Countries must therefore instigate national cancer control programmes aimed at preventing cancer, and with some urgency, if such programmes are to yield the desired public health and economic benefits in this century.
引用
收藏
页码:663 / 672
页数:10
相关论文
共 96 条
  • [1] Allen L, 2017, LANCET GLOB HEALTH, V5, pE277, DOI [10.1016/S2214-109X(17)30058-X, 10.1016/s2214-109x(17)30058-x]
  • [2] Priority-setting for obesity prevention-The Assessing Cost-Effectiveness of obesity prevention policies in Australia (ACE-Obesity Policy) study
    Ananthapavan, Jaithri
    Sacks, Gary
    Brown, Vicki
    Moodie, Marj
    Nguyen, Phuong
    Veerman, Lennert
    Herrera, Ana Maria Mantilla
    Lal, Anita
    Peeters, Anna
    Carter, Rob
    [J]. PLOS ONE, 2020, 15 (06):
  • [3] Tackling the tobacco epidemic in the Nordic countries and lower cancer incidence by 1/5 in a 30-year period-The effect of envisaged scenarios changing smoking prevalence
    Andersson, Therese M-L.
    Engholm, Gerda
    Brink, Anne-Line
    Pukkala, Eero
    Stenbeck, Magnus
    Tryggvadottir, Laufey
    Weiderpass, Elisabete
    Storm, Hans
    [J]. EUROPEAN JOURNAL OF CANCER, 2018, 103 : 288 - 298
  • [4] Avoidable cancer cases in the Nordic countries - The impact of overweight and obesity
    Andersson, Therese M-L.
    Weiderpass, Elisabete
    Engholm, Gerda
    Lund, Anne-Sofie Q.
    Olafsdottir, Elinborg
    Pukkala, Eero
    Stenbeck, Magnus
    Storm, Hans
    [J]. EUROPEAN JOURNAL OF CANCER, 2017, 79 : 106 - 118
  • [5] [Anonymous], 2013, Human Development Report 2013: The Rise of the South: Human Progress in a Diverse World
  • [6] In Mexico, Evidence Of Sustained Consumer Response Two Years After Implementing A Sugar-Sweetened Beverage Tax
    Arantxa Colchero, M.
    Rivera-Dommarco, Juan
    Popkin, Barry M.
    Ng, Shu Wen
    [J]. HEALTH AFFAIRS, 2017, 36 (03) : 564 - 571
  • [7] Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
    Arbyn, Marc
    Weiderpass, Elisabete
    Bruni, Laia
    de Sanjose, Silvia
    Saraiya, Mona
    Ferlay, Jacques
    Bray, Freddie
    [J]. LANCET GLOBAL HEALTH, 2020, 8 (02): : E191 - E203
  • [8] Global burden of cancer attributable to high body-mass index in 2012: a population-based study
    Arnold, Melina
    Pandeya, Nirmala
    Byrnes, Graham
    Renehan, Andrew G.
    Stevens, Gretchen A.
    Ezzati, Majid
    Ferlay, Jacques
    Miranda, J. Jaime
    Romieu, Isabelle
    Dikshit, Rajesh
    Forman, David
    Soerjomataram, Isabelle
    [J]. LANCET ONCOLOGY, 2015, 16 (01) : 36 - 46
  • [9] Modelling the health benefits of smoking cessation in Japan
    Avila-Tang, E.
    Apelberg, B. J.
    Yamaguchi, N.
    Katanoda, K.
    Sobue, T.
    Samet, J. M.
    [J]. TOBACCO CONTROL, 2009, 18 (01) : 10 - 17
  • [10] Cost-Effectiveness Of The Sugar-Sweetened Beverage Excise Tax In Mexico
    Basto-Abreu, Ana
    Barrientos-Gutierrez, Tonatiuh
    Vidana-Perez, Desiree
    Arantxa Colchero, M.
    Hernandez-F, Mauricio
    Hernandez-Avila, Mauricio
    Ward, Zachary J.
    Long, Michael W.
    Gortmaker, Steven L.
    [J]. HEALTH AFFAIRS, 2019, 38 (11) : 1824 - 1831